| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1.
|
Cancer Discov
|
2012
|
2.68
|
|
2
|
Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene.
|
J Natl Cancer Inst
|
2007
|
1.79
|
|
3
|
Sex determining region Y-Box 2 (SOX2) is a potential cell-lineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lung.
|
PLoS One
|
2010
|
1.69
|
|
4
|
Abnormalities of the TITF-1 lineage-specific oncogene in NSCLC: implications in lung cancer pathogenesis and prognosis.
|
Clin Cancer Res
|
2011
|
1.33
|
|
5
|
Validation of a proliferation-based expression signature as prognostic marker in early stage lung adenocarcinoma.
|
Clin Cancer Res
|
2013
|
1.13
|
|
6
|
Knockout of the tumor suppressor gene Gprc5a in mice leads to NF-kappaB activation in airway epithelium and promotes lung inflammation and tumorigenesis.
|
Cancer Prev Res (Phila)
|
2010
|
1.11
|
|
7
|
Tissue platinum concentration and tumor response in non-small-cell lung cancer.
|
J Clin Oncol
|
2012
|
1.11
|
|
8
|
Transcriptomic architecture of the adjacent airway field cancerization in non-small cell lung cancer.
|
J Natl Cancer Inst
|
2014
|
1.04
|
|
9
|
Characterizing the molecular spatial and temporal field of injury in early-stage smoker non-small cell lung cancer patients after definitive surgery by expression profiling.
|
Cancer Prev Res (Phila)
|
2012
|
0.92
|
|
10
|
Gprc5a deletion enhances the transformed phenotype in normal and malignant lung epithelial cells by eliciting persistent Stat3 signaling induced by autocrine leukemia inhibitory factor.
|
Cancer Res
|
2010
|
0.91
|
|
11
|
Comparable molecular alterations in 4-nitroquinoline 1-oxide-induced oral and esophageal cancer in mice and in human esophageal cancer, associated with poor prognosis of patients.
|
In Vivo
|
2013
|
0.85
|
|
12
|
A Gprc5a tumor suppressor loss of expression signature is conserved, prevalent, and associated with survival in human lung adenocarcinomas.
|
Neoplasia
|
2010
|
0.84
|
|
13
|
Expression of thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase, E2F-1, Bak, Bcl-X, and Bcl-2, and clinical outcomes for gastric cancer patients treated with bolus 5-fluorouracil.
|
Oncol Rep
|
2004
|
0.83
|
|
14
|
Phase II trials of imatinib mesylate and docetaxel in patients with metastatic non-small cell lung cancer and head and neck squamous cell carcinoma.
|
J Thorac Oncol
|
2011
|
0.82
|
|
15
|
HER family receptor and ligand status in thymic carcinoma.
|
Lung Cancer
|
2012
|
0.81
|
|
16
|
Validation of SCT Methylation as a Hallmark Biomarker for Lung Cancers.
|
J Thorac Oncol
|
2015
|
0.77
|
|
17
|
Primary Mediastinal Yolk Sac Tumors: An Immunohistochemical Analysis of 14 Cases.
|
Appl Immunohistochem Mol Morphol
|
2016
|
0.75
|